It’s Pioneer Institute vs. ICER: Drug-pricing watchdog comes under fire for a ‘one-size-fits-all’ approach
An influential Boston-based watchdog group uses a “one-size-fits-all” approach to judge a fair price for prescription drugs, a mindset ill-suited for a growing wave of expensive medicines that treat rare diseases, according to a new report by a think tank.
